학술논문
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases
Document Type
Article
Author
Papagoras, C.; Zioga, N.; Papadopoulos, V.; Gerolymatou, N.; Voulgari, P.V.; Kalavri, E.; Bounos, C.; Elezoglou, A.; Simopoulou, T.; Bogdanos, D.P.; Fragoulis, G.E.; Panopoulos, S.; Fragiadaki, K.; Evangelatos, G.; Bournia, V.-K.; Arida, A.; Karamanakos, A.; Pappa, M.; Kravvariti, E.; Tektonidou, M.G.; Sfikakis, P.P.; Deftereou, K.; Kougkas, N.; Dimitroulas, T.; Zampeli, E.; Kataxaki, E.; Melissaropoulos, K.; Georgiou, P.; Barouta, G.; Panagiotopoulos, A.; Koutsianas, C.; Vassilopoulos, D.; Liossis, S.-N.
Source
In: Clinical Rheumatology . (Clinical Rheumatology, December 2023, 42(12):3375-3385)
Subject
Language
English
ISSN
14349949
07703198
07703198